Vivo Ventures Fund VI, L.P.
10% owner at Sagent Pharmaceuticals, Inc.; 10% owner at AVANIR PHARMACEUTICALS
- Sold, on record
- $11.9M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 4, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Sagent Pharmaceuticals, Inc.10% owner
- AVANIR PHARMACEUTICALS10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Sagent Pharmaceuticals, Inc.696,823 shares
- AVANIR PHARMACEUTICALS411,366 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AVANIR PHARMACEUTICALSPlan not statedJul 31, 2009 2009
Sold 411,366 shares at $2.32 ($956k)
Vivo Ventures Fund VI, L.P., 10% owner
Sold 4.7% of holdings ($20.3M position)8.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale Sagent Pharmaceuticals, Inc.UnusualNov 4, 2015 +2287 days
Sold 696,823 shares at $15.72 ($11M)
Vivo Ventures Fund VI, L.P., 10% owner
Sold 96.5% of holdings ($11.4M position)25,337 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2015 | Nov 4, 2015 | Sagent Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 696,823 | $11M | 96.5% | Unusual | SEC |
| Jul 31, 2009 | Aug 3, 2009 | AVANIR PHARMACEUTICALS | 10% owner | Form 4 sale | 411,366 | $956k | 4.7% | Plan not stated | SEC |